News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Tower Semiconductor signed $1.3 billion in silicon photonics contracts for 2027 and secured $290 million in prepayments to fund capacity expansion.
  • Wolfspeed shares jumped 20% after a thematic research firm named it an AI-infrastructure standout, extending a multi-day semiconductor rally.
  • Nvidia CEO Jensen Huang joined President Trump on a trip to China, boosting sentiment for AI-infrastructure suppliers.
  • Gilat reported Q1 revenue rose 20% to $110.5 million and delivered GAAP operating income, reaffirming 2026 growth and EBITDA guidance.
  • Vishay posted Q1 revenue of $839.2 million with a strong 1.34 book-to-bill and reaffirmed higher Q2 revenue and margin guidance.
  • Quaest poll shows Lula 42% and Flavio Bolsonaro 41% in a simulated runoff, signaling a tight October presidential race.
  • J.P. Morgan downgraded Heineken to neutral citing leadership uncertainty, flagging potential slowdown in momentum into Q2.

Latest Articles

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

BioAge Labs, a clinical-stage biopharmaceutical company, will host an R&D Day webcast on May 8, 2026, presenting Phase 1 clinical data and the development rationale for BGE-102, a novel NLRP3 inflammasome inhibitor. The presentation includes insights from leading experts on NLRP3 biology and potential treatments for atherosclerotic cardiovascular d…

Cabot Corporation Board Increases Dividend

Cabot Corporation Board Increases Dividend

Cabot Corporation's Board of Directors declared a 5% increase in its quarterly dividend to $0.4725 per share, payable June 12, 2026. The raise highlights confidence in the company's strong cash flow, liquidity, and earnings durability, while maintaining investment capacity and a flexible balance sheet.

H&R Block Announces Quarterly Cash Dividend

H&R Block Announces Quarterly Cash Dividend

H&R Block announced a quarterly cash dividend of $0.42 per share payable in July 2026, reinforcing its long-standing history of dividend payments. The company has increased its dividend by 110% since 2016 and has returned over $5 billion to shareholders through dividends and share buybacks. H&R Block continues to provide tax preparation services an…

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

CVRx, Inc. has enrolled the first patient in its large-scale BENEFIT-HF trial, designed to evaluate the efficacy of its Barostim device in a significantly expanded heart failure population. The landmark randomized trial aims to enroll 2,500 patients across US and Germany centers, assessing all-cause mortality and heart failure decompensation events…

TOP Financial Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

TOP Financial Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

TOP Financial Group Limited announced it received a Nasdaq notification for failing to maintain the minimum $1.00 bid price for 30 consecutive business days. The company has 180 days to regain compliance or face potential delisting actions, including a possible reverse stock split. The notification does not affect current trading but signals risk i…

Teva to Present at the BofA Securities Health Care Conference

Teva to Present at the BofA Securities Health Care Conference

Teva Pharmaceutical Industries Ltd. announced that Eric Hughes, EVP of Global R&D and Chief Medical Officer, will present at the BofA Securities Health Care Conference on May 12, 2026. The presentation will discuss company strategies, innovations in pharmaceuticals and provide insights into their product pipeline and market approach.

U.S. equities slip at Monday close as cyclical sectors weigh on market

U.S. equities slip at Monday close as cyclical sectors weigh on market

U.S. stock averages finished lower on Monday, with the Dow Jones Industrial Average falling 1.13% and declines centered in Basic Materials, Industrials and Financials. The S&P 500 retreated 0.41% and the Nasdaq Composite dipped 0.19%. A mix of outsized winners on the S&P 500 and the Nasdaq contrasted with steep drops among select logistics and reta…

Vornado Announces First Quarter 2026 Financial Results

Vornado Announces First Quarter 2026 Financial Results

Vornado Realty Trust announced its financial results for the first quarter ended March 31, 2026, reporting a net loss attributable to common shareholders of $22.8 million versus net income of $86.8 million in the prior year quarter. Funds From Operations (FFO) per share decreased to $0.49 from $0.67 in the prior year. The company continued active r…

S&P Global CEO Catherine Clay Executes $1.08 Million Stock Purchase

S&P Global CEO Catherine Clay Executes $1.08 Million Stock Purchase

Catherine R. Clay, the Chief Executive Officer of S&P Dow Jones Indices, has made a significant direct investment in her company. On May 1, 2026, Clay acquired 2,500 shares of S&P Global Inc. (NASDAQ: SPGI) common stock. The transaction was executed at a price of $431.39 per share, resulting in a total purchase value of $1,078,475. Following this a…

Belite Bio Chief Scientific Officer Executes Planned Stock Sale

Belite Bio Chief Scientific Officer Executes Planned Stock Sale

Nathan L. Mata, the Chief Scientific Officer at Belite Bio, Inc. (NASDAQ: BLTE), has completed a sale of 1,000 American depositary shares. The transaction, valued at approximately $155,777, took place on May 1, 2026. This sale was conducted under a Rule 10b5-1 trading plan that Mata had previously established on December 10, 2025. Following this di…

Powell Industries Announces Second Quarter Fiscal 2026 Results

Powell Industries Announces Second Quarter Fiscal 2026 Results

Powell Industries announced its second quarter Fiscal 2026 results, highlighting a 6% revenue increase to $297 million, a record backlog of $1.8 billion, and new orders nearly doubling year-over-year to $490 million. Net income remained stable at $45.9 million despite higher expenses. Post-quarter, the company secured its largest-ever $400 million …